Source comparison
AOD-9604 Dosage for Bone Repair: Protocol Comparison
| Protocol Type | Daily Dose | Injection Frequency | Duration | Bone Density Increase (Preclinical) | Optimal Use Case | Professional Assessment ||—|—|—|—|—|—|| Standard Repair | 300mcg | Once daily | 4–6 weeks | 12–18% vs baseline | Acute fractures, post-surg
This comparison does not assign a generated winner or score.
- | Protocol Type | Daily Dose | Injection Frequency | Duration | Bone Density Increase (Preclinical) | Optimal Use Case | Professional Assessment ||—|—|—|—|—|—|| Standard Repair | 300mcg | Once daily | 4–6 weeks | 12–18% vs baseline | Acute fractures, post-surgical healing, moderate osteopenia | Gold standard. Aligns with natural callus formation timeline, maintains therapeutic plasma levels || Extended Maintenance | 150mcg | Once daily | 8–12 weeks | 8–14% vs baseline | Chronic non-union fractures, delayed healing in metabolic bone disease | Useful when initial 6-week protocol shows incomplete consolidation; lower dose reduces cost without sacrificing efficacy || Pulsed High-Dose | 600mcg | 3× weekly | 6 weeks | 9–13% vs baseline | None recommended | Suboptimal. Creates plasma concentration gaps that fall below osteoblast activation threshold between doses; no advantage over daily administration || Fat Loss Protocol (Misapplied) | 500mcg | Once daily | 12+ weeks | No skeletal benefit m